Fitch Revises GSK's Outlook to Negative; Affirms at 'A' - Fitch Research

Fitch Revises GSK's Outlook to Negative; Affirms at 'A'

Fitch Revises GSK's Outlook to Negative; Affirms at 'A' - Fitch Research
Fitch Revises GSK's Outlook to Negative; Affirms at 'A'
Published Apr 11, 2018
3259 words — Published Apr 11, 2018
Price US$ 149.00  |  Buy this Report Now

About This Report

  
Brief Excerpt:

Fitch Revises GSK's Outlook to Negative; Affirms at 'A' 11 Apr 2018 2:32 PM (EDT) Fitch Ratings-London-11 April 2018: Fitch Ratings has revised UK-based pharmaceuticals group GlaxoSmithKline PLC's (GSK) Outlook to Negative from Stable,...

  
Report Type:

Press Release

Company(ies)
GSK PLC , GlaxoSmithKline Finance PLC , Glaxosmithkline Capital Plc , Glaxosmithkline Capital Inc.
Ticker(s)
GSK
Issuer
GSK PLC
Format:
HTML HTML
Buy Now

Fitch Research—Fitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.

About the Author


Cite this Report

  
MLA:
Fitch Research. "Fitch Revises GSK's Outlook to Negative; Affirms at 'A'" Apr 11, 2018. Alacra Store. May 13, 2025. <http://www.alacrastore.com/fitch-credit-research/Fitch-Revises-GSK-s-Outlook-to-Negative-Affirms-at-A-1038988_pr_frame>
  
APA:
Fitch Research. (). Fitch Revises GSK's Outlook to Negative; Affirms at 'A' Apr 11, 2018. New York, NY: Alacra Store. Retrieved May 13, 2025 from <http://www.alacrastore.com/fitch-credit-research/Fitch-Revises-GSK-s-Outlook-to-Negative-Affirms-at-A-1038988_pr_frame>
  
US$ 149.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.